GEN News Highlights: Mar 14, 2011

Complete Genomics Taps DNAnexus’ Cloud-Based Informatics Solution

(Page 1 of 1)

    Complete Genomics has leveraged DNAnexus’ cloud-based platform with which customers can store and visualize their human genome sequencing data. Additionally, DNAnexus will host the publicly available Complete Genomics human genome datasets and make them available as reference data to all its customers.

    Through the DNAnexus platform, Complete Genomics’ customers can, for example, simultaneously visualize structural variations, copy number variations, and small variants in the DNAnexus Genome Browser. Built on Amazon Web Services, DNAnexus is a platform for analyzing, managing, and storing DNA sequencing data. DNAnexus acquires computational and storage resources on demand from Amazon on behalf of each user to provide scalability and pricing that mirrors usage—whether a user is investigating one or thousands of genomes.

    “As we continue to refine our genome-sequencing service, we want to make sure that our customers have access to the best tools available to interpret the rich datasets that we provide,” says Mark Sutherland, svp of business development at Complete Genomics. “We have worked closely with DNAnexus to ensure that its informatics platform will support our detailed sequence data and thus allow our customers to capitalize on its visualization capabilities.”

    Moving forward, DNAnexus will integrate Complete Genomics Analysis Tools (CGA™ Tools) functionality into DNAnexus, further enabling customers to interrogate their data. The integration of the CGA Tools, an open-source software project that provides solutions for downstream analysis of data produced by Complete Genomics, will allow researchers to take on complex multigenome comparisons, the companies say.


Related content

GEN News Highlights

Insight & Intelligence™

GEN Articles

BLOG biotech

Application Notes

Webinars

GEN Podcasts

New Products

Best of the Web

GEN Polls

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

FDA Performance

How much progress do you think FDA has made in reviewing drugs and bringing them to market faster?

Suggest a Poll